RBM10, a New Regulator of p53

• Published in: Cells (Basel, Switzerland) Vol. 9; no. 9; p. 2107
• Main Authors: Jung, Ji Hoon, Lee, Hyemin, Zeng, Shelya X, Lu, Hua
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 16.09.2020; MDPI
• Subjects: Adenocarcinoma of Lung - genetics; Adenocarcinoma of Lung - metabolism; Adenocarcinoma of Lung - pathology; Alternative Splicing; apoptosis; Apoptosis - genetics; cancer; Carcinoma, Pancreatic Ductal - genetics; Carcinoma, Pancreatic Ductal - metabolism; Carcinoma, Pancreatic Ductal - pathology; Cell Cycle Checkpoints - genetics; Cell Movement; Cell Proliferation; Cellular Senescence; Cleft Palate - genetics; Cleft Palate - metabolism; Cleft Palate - pathology; Colorectal Neoplasms - genetics; Colorectal Neoplasms - metabolism; Colorectal Neoplasms - pathology; Gene Expression Regulation, Neoplastic; Health aspects; Heart Defects, Congenital - genetics; Heart Defects, Congenital - metabolism; Heart Defects, Congenital - pathology; Humans; MDM2; Neovascularization, Pathologic - genetics; Neovascularization, Pathologic - metabolism; Neovascularization, Pathologic - pathology; p53; RBM10; Review; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism; Signal Transduction; Tumor suppressor genes; Tumor Suppressor Protein p53 - genetics; Tumor Suppressor Protein p53 - metabolism; United States; MDM2; apoptosis; cancer; RBM10; p53
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells9092107

The tumor suppressor p53 acts as a transcription factor that regulates the expression of a number of genes responsible for DNA repair, cell cycle arrest, metabolism, cell migration, angiogenesis, ferroptosis, senescence, and apoptosis. It is the most commonly silenced or mutated gene in cancer, as approximately 50% of all types of human cancers harbor TP53 mutations. Activation of p53 is detrimental to normal cells, thus it is tightly regulated via multiple mechanisms. One of the recently identified regulators of p53 is RNA-binding motif protein 10 (RBM10). RBM10 is an RNA-binding protein frequently deleted or mutated in cancer cells. Its loss of function results in various deformities, such as cleft palate and malformation of the heart, and diseases such as lung adenocarcinoma. In addition, RBM10 mutations are frequently observed in lung adenocarcinomas, colorectal carcinomas, and pancreatic ductal adenocarcinomas. RBM10 plays a regulatory role in alternative splicing. Several recent studies not only linked this splicing regulation of RBM10 to cancer development, but also bridged RBM10's anticancer function to the p53 pathway. This review will focus on the current progress in our understanding of RBM10 regulation of p53, and its role in p53-dependent cancer prevention.